These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis. Luo T, Chen J, Liu JJ, Li H, You XM, Wang HL, Zhu SL, Li LQ. Onco Targets Ther; 2016; 9():4483-9. PubMed ID: 27499641 [Abstract] [Full Text] [Related]
26. The association of CTLA-4 A49G polymorphism with colorectal cancer risk in a Chinese Han population. Wang Y, Wang X, Zhao R. Int J Immunogenet; 2015 Apr; 42(2):93-9. PubMed ID: 25689638 [Abstract] [Full Text] [Related]
27. Lack of association between leptin G-2548A polymorphisms and obesity risk: Evidence based on a meta-analysis. Yan J, Wang X, Tao H, Yang W, Luo M, Lin F. Obes Res Clin Pract; 2015 Apr; 9(4):389-97. PubMed ID: 25733497 [Abstract] [Full Text] [Related]
28. Association between CTLA-4 exon-1 +49A/G polymorphism and asthma: an updated meta-analysis. Yao YS, Wang LH, Chang WW, He LP, Li J, Jin YL, Li CP. Int J Clin Exp Med; 2015 Apr; 8(3):3107-13. PubMed ID: 26064199 [Abstract] [Full Text] [Related]
29. Association of -319 C/T and +49 A/G polymorphisms of CTLA-4 gene in patients with hepatitis C virus infection. Enciso-Vargas M, Ruíz-Madrigal B, Muñoz-Valle JF, Morales-Balderas OY, Hernández-Nazara ZH, Martínez-López E, Dávalos-Cobian C, Padilla-Gutiérrez JR, Torres-Baranda JR, Domínguez-Rosales JA, Maldonado-González M. Med Clin (Barc); 2018 Apr 13; 150(7):251-256. PubMed ID: 29033194 [Abstract] [Full Text] [Related]
30. Effect of cytotoxic T-lymphocyte antigen-4, TNF-alpha polymorphisms on osteosarcoma: evidences from a meta-analysis. Liu J, Wang J, Jiang W, Tang Y. Chin J Cancer Res; 2013 Dec 13; 25(6):671-8. PubMed ID: 24385694 [Abstract] [Full Text] [Related]
35. Association of TNF-α-308 and -238 polymorphisms with risk of cervical cancer: a meta-analysis. Pan F, Tian J, Ji CS, He YF, Han XH, Wang Y, Du JP, Jiang FS, Zhang Y, Pan YY, Hu B. Asian Pac J Cancer Prev; 2012 Dec 13; 13(11):5777-83. PubMed ID: 23317256 [Abstract] [Full Text] [Related]
36. The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis. Wang J, Ding Q, Shi Y, Cao Q, Qin C, Zhu J, Chen J, Yin C. Mutagenesis; 2012 May 13; 27(3):305-12. PubMed ID: 22058059 [Abstract] [Full Text] [Related]
37. XPA A23G polymorphism and risk of digestive system cancers: a meta-analysis. He L, Deng T, Luo H. Onco Targets Ther; 2015 May 13; 8():385-94. PubMed ID: 25709470 [Abstract] [Full Text] [Related]